All In MedTech

Device Trial Radar · NCT03927508

First - In - Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism

Last checked: Nov 20, 2026Latest source record: Mar 30, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

9

Actual

Start

Mar 14, 2019

Primary completion

Dec 19, 2019

Study completion Jan 23, 2020

Sponsor

Lead sponsor
Thrombolex, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Apr 25, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Bashir™ Endovascular Catheter is a device intended for the localized infusion of therapeutic agents into the pulmonary artery and peripheral vasculature.

Conditions

  • Pulmonary Embolism

Interventions

  • r-tPADrug

    Pulse spray and infusion

  • The Bashir™ Endovascular CatheterDevice

    The Bashir™ Endovascular Catheter is a device intended for the localized infusion of therapeutic agents into the pulmonary artery and peripheral vasculature.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety: Number of Participants With Major Bleeding EventsTime frame: Within 72 hours of initiation of r-tPA administration.

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Advent Health Orlando

    Orlando, Florida

  • St Vincent Hospital and Health Care Center, Inc.

    Indianapolis, Indiana

  • Columbia University Medical Center - Presbyterian - New York

    New York, New York

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.